Tweet by Dr. John Cush

Tweet
Dr. John Cush @RheumNow Nov 5, 2022
View on
New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes?

This and more on the latest RheumNow podcast.
https://bit.ly/3WxS9LK
Image from Dr. John Cush’s tweet

Related Content

Video Education/ACR/EULAR

DERM on RheumNow PODCAST (September 2026)

Sep 30, 2026
The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, calcinosis, CTD skin disorders. dermatology drugs, biologics, and JAK inhibitors.Features Dr. Jack Cush, Editor at RheumNow.com.Show Notes:FDA Grants Priority Review…
Podcast

DERM on RheumNow PODCAST (October 2026)

RheumNow Oct 31, 2026
Every day, every month, rheumatology publishes news and reports on JAK inhibitors, IL-17s, IL-23s, lupus, myositis, and scleroderma – all which could change how you practice dermatology. I'm Jack Cush from RheumNow, and This is Derm on RheumNow. This month’s podcast will Scratch the surface and…
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Topics

×